S&P Says Still Accumulate Pfizer as New Impotance Drugs Enter the Market

Pfizer (PFE ) and Lilly (LLY ): Maintains 4 STARS (accumulate); and GlaxoSmithKline (GSK ): Maintains 3 STARS (hold)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.